Comparison of Two Therapies for Upper Esophageal Sphincter (UES) Dysphagia
NCT ID: NCT00059670
Last Updated: 2010-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
204 participants
INTERVENTIONAL
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary objective of this 5-year project is to identify which of two therapy programs, the Shaker exercise versus traditional therapy, results in the largest number of stable, non-oral dysphagic patients who can swallow safely and return to full oral feeding after 6 weeks of intervention. The study is powered adequately so that this aim can be tested separately for head and neck cancer and stroke patients. Our primary outcome measure is return to oral feeding, i.e., 100% of nutrition and hydration by mouth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
External UES Band (Shaker Pressure Band) and GERD
NCT05697393
Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
NCT02959450
Standardized Dysphagia Diet in Clinical Evaluation of Swallowing Function
NCT05634980
Effect of Manual Diaphragmatic Activation on Diaphragm Function in Patients With Gastroesophageal Reflux Disease
NCT06268548
Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia
NCT00001718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Determine in a descriptive manner whether patients with residue in the pyriform sinuses who aspirate the residue after the swallow respond better, i.e., a higher percentage of them can return to 100% oral intake, than patients with residue in the valleculae who aspirate after the swallow or patients with residue in both locations who aspirate after the swallow and thus to define the spectrum of indications for the proposed exercise programs in the two groups of dysphagic patients (stroke and post-chemo radiation treatment for head and neck cancer) and whether postures enable each patient type to swallow more bolus types without aspiration at pre- and post
2. Define the pathophysiology underlying the swallow dysfunction and those pathophysiologic elements which change as a result of each therapy program including changes in -
1. anteroposterior and lateral diameter of maximum deglutitive UES opening
2. maximum deglutitive laryngeal anterior and superior excursions
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shaker Exercise vs. Traditional Dysphagia Therapy Regime
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Incomplete UES opening and post-deglutitive aspiration
* Hypopharyngeal (pyriform sinus) residue or vallecular residue alone or in combination
* Dysphagia requiring tube feeding (at least 3 months non-oral condition)
* Able to comply with protocol mandates, willing to perform the exercise programs, and ability to attend study sessions.
Exclusion Criteria
* Other neuromuscular disorders such as
* Lack of cognition
* Metabolic myopathies
* History of alcoholic neuropathy
* Steroid myopathy
* Cervical spine injury, lesions, or large osteophytes
* Kerns-Sayers Syndrome
* Individuals unable to exercise independently
* Oculo-pharyngeal and other dystrophies
* Current use of anticholinergics:
bensodiazopin, antihistamines
* Myasthenia gravis
* Elimination of aspiration with posture during VFG
* Absent pharyngeal swallow on VFG
* Aspiration before or during the swallow (pre and intradeglutitive aspiration)
* Not completely tube feeding dependent
21 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reza Shaker, M.D.
Role: PRINCIPAL_INVESTIGATOR
Professor and Chief, Division of Gastroenterology and Hepatology, Director, Digestive Disease Center, Medical College of Wisconsin
Jerilyn A. Logemann, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Professor Department of Communication Sciences and Disorders, Ralph and Jean Sundin Professor of Communication Sciences and Disorders, Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical College University of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shaker R, Easterling C, Kern M, Nitschke T, Massey B, Daniels S, Grande B, Kazandjian M, Dikeman K. Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology. 2002 May;122(5):1314-21. doi: 10.1053/gast.2002.32999.
Related Links
Access external resources that provide additional context or updates about the study.
Division of Gastroenterology and Hepatology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESD (completed)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.